Halma on track for targets

Environmental technology health and safety group Halma said based on current trading and forecasts, it expects adjusted profit for the full year to be in line with market expectations.

Environmental technology health and safety group Halma said based on current trading and forecasts, it expects adjusted profit for the full year to be in line with market expectations.

In an update ahead of its results for the year ending March 30th, the group said regional and sector trading patterns reported for the first six months of the financial year have been maintained.

Across its geographical regions good growth has continued in the US and Asia whilst tougher trading conditions remain in the UK and Europe.

Its Industrial Safety sector performed strongly while Health & Analysis was boosted by recent acquisitions. Good performances in Health Optics and Fluid Technology offset weakness in Photonics.

Elsewhere Infrastructure Sensors made solid progress with the expected improvement in Elevator Safety and softer trading in Automatic Door Sensors.

"This financial year we have made five acquisitions and one disposal. All acquisitions, including MicroSurgical Technology and Longer Pump, which were acquired in December 2012 and January 2013 respectively, are trading well and in line with our expectations," the group said in a statement.

"We have maintained strong returns and achieved good cash generation, which provide us with the financial capacity for further acquisitions and investment. We continue to search for opportunities across all of Halma's market sectors."

Halma said there have been no material events or transactions impacting the group's financial position, which remains strong.

CJ

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Aviva: a share for income investors to tuck away
Share tips

Aviva: a share for income investors to tuck away

Insurance giant Aviva is one of the highest yielding stocks in the FTSE 100 – and it’s cheap, too, making it a tempting target for income investors. R…
18 May 2022
Despite the crypto crash, bitcoin still has a bright future
Bitcoin & crypto

Despite the crypto crash, bitcoin still has a bright future

Cryptocurrencies have crashed hard, with bitcoin down by more than 50% from its peak. But, says Dominic Frisby, bitcoin still has a future – it is the…
19 May 2022